WASHINGTON -- The deals that the White House cut with major industries during the health care debate are threatening to come back to haunt the adminis...

In the coming years, NORML will join other local and national organizations in challenging the pharmaceutical remodeling of medical marijuana, a looming political trend that they call "anti-pleasure seeking, hypocritical" policy toward intoxicating drugs.

It did not take long for the conflicts to emerge as Republicans struggle to make good on their commitments to reduce federal spending. In the wake of ...

Al only gave me a day before he called back. "So what's the scoop on health care? Are Americans the best or the worst off? All this noise about the n...

WASHINGTON — Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President ...

Health care special-interest groups may not have a direct seat at the table at Thursday's bipartisan health care reform summit, but they will hardly b...

Within a few months of being sworn in, the President and his aides were sitting down with leaders from the pharma industry to hash out a deal that they thought would make health care reform possible.